Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
Pilot study aiming to assess the effect of two doses of rhu EPO on urine NGAL concentration
and on serum cystatin C and creatinine levels in critically ill patients at risk of ARF.